Bureau Of Pharma Psus Of India

Rediff.com » News » Bureau Of Pharma Psus Of India

News for Bureau Of Pharma Psus Of India

Business

2 reasons why drug sales are in poor health

Overall slowdown in the economy and growing volumes of unbranded generic medicines in the domestic market are behind poor sales. Illustration: Uttam Ghosh/Rediff.com Sales volume of pharmaceutical......

Quality perceptions hobble Jan Aushadi drugs

Large pharmaceutical firms feel that if the quality parameters and assurance levels are brought up to the level of branded generics, then Jan Aushadhi medicines would find it difficult to retain......

People's medicine scheme is a non-performer

The Pradhan Mantri Jan Aushadhi Yojana or PMJAY has not been a runaway success by any yardstick. Not all stores are running, and many are poorly stocked. IMAGE: A Jan Aushadhi shop being......

India Inc pays 53% more dividend in '02-03

Shareholders, both individuals and the government, have not had it so good in recent times. Corporate India is sharing the bounty of a good 2002-03 by paying higher dividends.A Business Standard......

Market weak; PSUs decline

A weakness in PSU stocks following disappointment over the delay in divestment of HPCL and BPCL, a surge in oil prices amid fears of an US-Iraq war and an oil strike in Venezuela, profit taking in......

Rediff News

Bureau Of Pharma Psus Of India

News for Bureau Of Pharma Psus Of India

2 reasons why drug sales are in poor health

Quality perceptions hobble Jan Aushadi drugs

People's medicine scheme is a non-performer

India Inc pays 53% more dividend in '02-03

Market weak; PSUs decline

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS